Abstract
The development of lung cancer is resulted by the interaction between genetic mutations and dynamic epigenetic alterations, although its mechanisms are not fully understood. Among the epigenetic alterations, DNA methylation is the most studied epigenetic regulatory mechanism. DNA methylation changes may be promising biomarker for early detection and prognosis in lung cancer. We evaluated serial changes of genome wide DNA methylation pattern in blood of lung cancer patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.